Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Eksterne analyser

Generic: Sales growth re-established above 10% - ABG

Generic Sweden

Dette er en ekstern analyse og afspejler ikke nødvendigvis vores perspektiv eller værdier.

Download analyse (PDF)
Finding a new level of growth post COVID-19
Impressive profitability in Q4
Low churn confirmed, as expected


Q4: Sales growth of 12% and an EBIT margin of 21.5%

Generic reported solid Q4 results with net sales of SEK 34.2m (+12% y-o-y). Growth picked up a bit more compared to Q3 (+11% y-o-y) as the company is finding a new plateau after the deal with The Swedish Social Insurance Office and COVID-19 boosted 2021. Sales were in line with ABGSCe but profitability clearly higher. EBIT was SEK 7.4m (5.1m) for a margin of 21.5% (16.8%). EBIT was 25% above ABGSCe, partly thanks to a higher gross margin but mainly due to lower personnel costs. The board proposed a dividend SEK 1.25 (1.00) per share.
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team